Big pharma model is being challenged
Shore Capital Healthcare Analyst, Tara Raveendran, discusses how innovation, coming from small and mid-cap companies, is challenging big pharma on CNBC.
Shore Capital Healthcare Analyst, Tara Raveendran, discusses how innovation, coming from small and mid-cap companies, is challenging big pharma on CNBC.